Filed before 2025Filed 4 August 2023
Bilayer Therapeutics, Inc. raised $300K
Bilayer Therapeutics, Inc., a biotech company based in Cambridge, MA, raised $300K in a new debt round, according to a filing dated 4 August 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 4 August 2023
- Round
- Debt round
- Amount sold
- $300K
- Offering size
- $1M
- Investors so far
- 1
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 4% of the 1,396 tracked raises with an amount filed in 2023, and than 4% of the 142 in biotech.
Bilayer Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Aug 2023 | New filing | $300K | This raise |
| 29 Apr 2021 | New filing | $2M | Another raise |
More with Kendall Capital on the board
- Noveome Biotherapeutics, Inc.$6.75M
- Rejuvenate Bio Inc$19.5M
- EpiBone, Inc.$4.29M
- VitaKey Inc.Undisclosed
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.